ATE236130T1 - Heterocyclisch substituierte imidazole zur behandlung von entzündungen - Google Patents
Heterocyclisch substituierte imidazole zur behandlung von entzündungenInfo
- Publication number
- ATE236130T1 ATE236130T1 AT97901952T AT97901952T ATE236130T1 AT E236130 T1 ATE236130 T1 AT E236130T1 AT 97901952 T AT97901952 T AT 97901952T AT 97901952 T AT97901952 T AT 97901952T AT E236130 T1 ATE236130 T1 AT E236130T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- protected
- halo
- forming
- hydroxyimidazole
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- -1 alkaxy Chemical group 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- AICIYIDUYNFPRY-UHFFFAOYSA-N 1,3-dihydro-2H-imidazol-2-one Chemical compound O=C1NC=CN1 AICIYIDUYNFPRY-UHFFFAOYSA-N 0.000 abstract 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 150000001409 amidines Chemical class 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001145 hydrido group Chemical group *[H] 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000004689 alkyl amino carbonyl alkyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 abstract 1
- 125000001769 aryl amino group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000005164 aryl thioalkyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004966 cyanoalkyl group Chemical group 0.000 abstract 1
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005366 cycloalkylthio group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 abstract 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005283 haloketone group Chemical group 0.000 abstract 1
- 125000004475 heteroaralkyl group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 abstract 1
- 125000005553 heteroaryloxy group Chemical group 0.000 abstract 1
- 125000005368 heteroarylthio group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59216796A | 1996-01-26 | 1996-01-26 | |
| PCT/US1997/000300 WO1997027181A1 (en) | 1996-01-26 | 1997-01-24 | Heterocyclo-substituted imidazoles for the treatment of inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE236130T1 true ATE236130T1 (de) | 2003-04-15 |
Family
ID=24369588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97901952T ATE236130T1 (de) | 1996-01-26 | 1997-01-24 | Heterocyclisch substituierte imidazole zur behandlung von entzündungen |
| AT01123289T ATE346849T1 (de) | 1996-01-26 | 1997-01-24 | Ein verfahren zur herstellung von 4- 2-(aryl oder heterocyclo)-1h-imidazol-1-ylöbenzolsulfonamide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01123289T ATE346849T1 (de) | 1996-01-26 | 1997-01-24 | Ein verfahren zur herstellung von 4- 2-(aryl oder heterocyclo)-1h-imidazol-1-ylöbenzolsulfonamide |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1193265B1 (de) |
| JP (1) | JP2000503987A (de) |
| AT (2) | ATE236130T1 (de) |
| AU (1) | AU730642B2 (de) |
| DE (3) | DE69737042D1 (de) |
| DK (2) | DK0880504T3 (de) |
| ES (2) | ES2197983T3 (de) |
| HK (1) | HK1045843B (de) |
| NZ (1) | NZ327022A (de) |
| PT (2) | PT880504E (de) |
| WO (1) | WO1997027181A1 (de) |
| ZA (1) | ZA97670B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| NZ333399A (en) | 1997-12-24 | 2000-05-26 | Sankyo Co | Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis |
| EP1052238A4 (de) | 1998-01-28 | 2007-05-02 | Shionogi & Co | Neue trizyklische verbindung |
| US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| US6410562B1 (en) | 1998-12-18 | 2002-06-25 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| ES2166710B1 (es) * | 2000-04-25 | 2004-10-16 | J. URIACH & CIA, S.A. | Nuevos compuestos heterociclicos con actividad antiinflamatoria. |
| AU2001256705A1 (en) * | 2000-05-15 | 2001-11-26 | Grelan Pharmaceutical Co. Ltd. | 1-(benzothiazol-2-yl)pyrazole derivatives and cox-2 inhibitors containing the same |
| US6555563B1 (en) * | 2001-11-16 | 2003-04-29 | Medinox, Inc. | Heteroaryl substituted amidinyl and imidazolyl compounds and methods employing same for the treatment of inflammation |
| WO2003084936A2 (en) * | 2002-04-10 | 2003-10-16 | Orchid Chemicals & Pharmaceuticals Limited | Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| US6878735B2 (en) * | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| US7211598B2 (en) | 2002-06-28 | 2007-05-01 | Nitromed, Inc. | Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| WO2004060367A1 (en) * | 2002-12-30 | 2004-07-22 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole and triazole derivatives useful as selective cox-1 inhibitors |
| ES2275218T3 (es) | 2003-05-07 | 2007-06-01 | Osteologix A/S | Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos. |
| BRPI0508552A (pt) * | 2004-03-08 | 2007-08-14 | Wyeth Corp | moduladores de canal de ìon |
| CN102584695B (zh) * | 2012-01-13 | 2014-02-19 | 江苏中邦制药有限公司 | 一种5-甲基烟酸的制备方法 |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3264492B2 (ja) * | 1992-01-13 | 2002-03-11 | スミスクライン・ビーチャム・コーポレイション | ピリジル置換イミダゾール |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5475018A (en) * | 1993-11-30 | 1995-12-12 | G. D. Searle & Co. | 1,5-diphenyl pyrazole compounds for treatment of inflammation |
| US5616601A (en) * | 1994-07-28 | 1997-04-01 | Gd Searle & Co | 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
-
1997
- 1997-01-24 NZ NZ327022A patent/NZ327022A/xx unknown
- 1997-01-24 JP JP9526876A patent/JP2000503987A/ja not_active Abandoned
- 1997-01-24 AT AT97901952T patent/ATE236130T1/de not_active IP Right Cessation
- 1997-01-24 ES ES97901952T patent/ES2197983T3/es not_active Expired - Lifetime
- 1997-01-24 PT PT97901952T patent/PT880504E/pt unknown
- 1997-01-24 DK DK97901952T patent/DK0880504T3/da active
- 1997-01-24 DE DE69737042A patent/DE69737042D1/de not_active Expired - Fee Related
- 1997-01-24 EP EP01123289A patent/EP1193265B1/de not_active Expired - Lifetime
- 1997-01-24 EP EP97901952A patent/EP0880504B1/de not_active Expired - Lifetime
- 1997-01-24 DE DE69737042T patent/DE69737042T8/de active Active
- 1997-01-24 DE DE69720428T patent/DE69720428T2/de not_active Expired - Fee Related
- 1997-01-24 DK DK01123289T patent/DK1193265T3/da active
- 1997-01-24 AU AU15739/97A patent/AU730642B2/en not_active Ceased
- 1997-01-24 ES ES01123289T patent/ES2274843T3/es not_active Expired - Lifetime
- 1997-01-24 AT AT01123289T patent/ATE346849T1/de not_active IP Right Cessation
- 1997-01-24 WO PCT/US1997/000300 patent/WO1997027181A1/en not_active Ceased
- 1997-01-24 PT PT01123289T patent/PT1193265E/pt unknown
- 1997-01-27 ZA ZA9700670A patent/ZA97670B/xx unknown
-
2002
- 2002-10-03 HK HK02107266.0A patent/HK1045843B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT880504E (pt) | 2003-08-29 |
| EP0880504A1 (de) | 1998-12-02 |
| DK0880504T3 (da) | 2003-07-21 |
| DE69737042T2 (de) | 2007-07-19 |
| NZ327022A (en) | 1999-06-29 |
| DE69720428T2 (de) | 2004-02-12 |
| ZA97670B (en) | 1998-04-16 |
| DE69720428D1 (de) | 2003-05-08 |
| EP1193265A3 (de) | 2002-04-10 |
| HK1045843B (en) | 2007-03-02 |
| HK1045843A1 (en) | 2002-12-13 |
| DE69737042T8 (de) | 2007-11-22 |
| PT1193265E (de) | 2007-03-30 |
| ES2274843T3 (es) | 2007-06-01 |
| AU730642B2 (en) | 2001-03-08 |
| ATE346849T1 (de) | 2006-12-15 |
| DE69737042D1 (de) | 2007-01-11 |
| JP2000503987A (ja) | 2000-04-04 |
| ES2197983T3 (es) | 2004-01-16 |
| WO1997027181A1 (en) | 1997-07-31 |
| EP1193265B1 (de) | 2006-11-29 |
| AU1573997A (en) | 1997-08-20 |
| DK1193265T3 (da) | 2007-02-19 |
| EP1193265A2 (de) | 2002-04-03 |
| EP0880504B1 (de) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69720428D1 (de) | Heterocyclisch substituierte imidazole zur behandlung von entzündungen | |
| ATE210648T1 (de) | 3,4-substituierte pyrazole zur behandlung von entzündungen | |
| KR880005093A (ko) | 5-알킬벤즈이미다졸, 그의 제조방법 및 이들을 함유하는 약제학적 조성물 | |
| ATE315397T1 (de) | Neurotrophin antagoniste zur behandlung von der epilepsie, alzheimer'schen krankheit und schmerzen | |
| ATE217613T1 (de) | Pyrazolderivate mit entzündunghemmender, analgetischer und antithrombotischer wirkung | |
| NZ334597A (en) | NO synthase inhibitors with trappers of oxygen reactive forms to treat nitric oxide synthase associated diseases | |
| ES2197160T3 (es) | Antagonistas fibronogeno bicicliclos. | |
| ES2183883T3 (es) | Compuestos de imidazolilo sustituidos en 1,2 para el tratamiento de la inflamacion. | |
| ES2120728T3 (es) | Inhibidores de la agregacion de plaquetas. | |
| RU94040154A (ru) | Производные фениламиносульфонилмочевины и их соли, гербицидное средство и способы борьбы с сорной растительностью | |
| ATE291018T1 (de) | Pyrazol verbindungen und ihre verwendung | |
| ATE72431T1 (de) | 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren. | |
| ES2110115T3 (es) | Inhibidores de la agregacion de plaquetas. | |
| KR890009867A (ko) | 비 펩타이드성 레닌 억제제 | |
| DK0804418T3 (da) | Platelataggregationshæmmere | |
| DE69417573D1 (de) | Tricyclische derivate und phamazeutische zusammensetzungen die sie enthalten | |
| WO2005060713A3 (en) | Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions | |
| DE69518159D1 (de) | Mittel zur vorsorge und heilung von typ i allergischen krankheiten | |
| KR880011149A (ko) | N-1h-테트라졸-5-일-2-티오펜카르복사미드, n-1h-테트라졸-5-일-2-피롤카르복사미드,n-1h-테트라졸-5-일-2-푸란 카르복사미드 | |
| RU94041225A (ru) | Антивирусные пептиды, способ получения, фармацевтическая композиция, способ лечения ретровирусных инфекций | |
| KR950703956A (ko) | 순환 장애 개선제[circulatory disturbance ameliorant] | |
| KR870009721A (ko) | N-아미노 4급화된 헤테로아릴륨 카바페넴 항균제 | |
| KR100348888B1 (en) | Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| KR900001696A (ko) | 궤양치료 활성을 갖는 1.4-디아제핀 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0880504 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |